Evidence map›Paper›PMID 32501546›Full record

Trial reportJournal of the American Geriatrics Society2020

Association of Sustained Blood Pressure Control with Multimorbidity Progression Among Older Adults.

C Barrett Bowling, Richard Sloane, Carl Pieper, Alison Luciano, Barry R Davis, Lara M Simpson, Paula T Einhorn, Suzanne Oparil, Paul Muntner

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Geriatrics Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Multimorbidity Management: A Scoping Review of Interventions and Health Outcomes.International journal of environmental research and public health · 2025
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C Barrett BowlingDurham Veterans Affairs Geriatric Research Education and Clinical Center, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA.
Richard SloaneCenter for Study of Aging and Human Development, Duke University, Durham, North Carolina, USA.
Carl PieperCenter for Study of Aging and Human Development, Duke University, Durham, North Carolina, USA.
Alison LucianoCenter for Study of Aging and Human Development, Duke University, Durham, North Carolina, USA.
Barry R DavisThe University of Texas School of Public Health, Houston, Texas, USA.
Lara M SimpsonThe University of Texas School of Public Health, Houston, Texas, USA.
Paula T EinhornDivision of Cardiovascular Sciences, National Heart, Lung, and Blood Institute of the National Institutes of Health, Bethesda, Maryland, USA.
Suzanne OparilDepartment of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Paul MuntnerDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
Sustained blood pressure control and progression of multimorbidityR01HL133618 · NHLBI · EMORY UNIVERSITY · PI BOWLING, CHRISTOPHER BARRETT · 2016 to 2019
$2.0M
NHLBI NIH HHS R01 HL133618NHLBI NIH HHS R01HL133618NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

BACKGROUND/

objectivesDue to the high costs and excess mortality associated with multimorbidity, there is a need to develop approaches for delaying its progression. High blood pressure (BP) is a common chronic condition and a risk factor for many additional chronic conditions, making it an ideal target for intervention. The purpose of this analysis was to determine the association between the level of sustained BP control and the progression of multimorbidity.

designRetrospective cohort study.

settingAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) linked to Medicare claims.

participantsA total of 6,591 ALLHAT participants with Medicare who had systolic BP (SBP) measurements at eight or more study visits. MEASUREMENTS: SBP control was categorized as lower than 140 mm Hg at less than 50%, 50% to less than 75%, 75% to less than 100%, and 100% of visits. Multimorbidity progression was defined by the number of incident chronic conditions, including arthritis, asthma, atrial fibrillation, cancer, chronic kidney disease, chronic obstructive pulmonary disease, coronary heart disease, dementia, depression, diabetes mellitus, heart failure, hyperlipidemia, osteoporosis, and stroke. Recurrent event survival analysis was used to calculate rate ratios (RRs) for the association of sustained SBP control with progression of multimorbidity.

resultsRates of incident conditions per 10 person-years (95% CIs) were 5.2 (5.1-5.4), 4.7 (4.5-4.8), 4.4 (4.2-4.5), and 4.0 (3.8-4.2) for participants with SBP control at less than 50%, 50% to less than 75%, 75% to less than 100%, and 100% of visits, respectively, over a median follow-up of 9.0 years. Compared with participants with SBP control at less than 50% of visits, adjusted RRs (95% CIs) for multimorbidity progression were 0.90 (0.86-0.95), 0.85 (0.81-0.89), and 0.77 (0.72-0.82) for those with SBP control at 50% to less than 75%, 75% to less than 100%, and 100% of visits, respectively.

conclusionsSustaining BP control may be an effective approach to slow multimorbidity progression and may reduce the population burden of multimorbidity.

Indexed as

Chronic DiseaseAgedAntihypertensive AgentsFemaleHumansHypertensionIncidenceMaleMedicareMultimorbidityRetrospective StudiesUnited StatesAntihypertensive Agentsagingblood pressure controlhypertensionmultimorbiditysystolic blood pressure

Identifiers

PMID32501546
PMCPMC7718414

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.